CCI to engage Agency to conduct Study on pharma sector
Published: Nov 23, 2017
By TIOLCORPLAWS News Service
NEW DELHI, NOV 23, 2017: AS Competition Commission of India (CCI) has made a request for proposal for the engagement of an agency for conducting a Study on the Pharmaceutical and Health Care Sector. In the enforcement experience of the Commission, several anti-competitive practices in the Indian Pharmaceutical and Healthcare sector have come to the fore. In order to understand the nature and magnitude of such practices, the Commission has decided to conduct a Study on Pharmaceutical and Health Care Sector in Delhi & three districts of NCR namely Gurgaon, Faridabad and NOIDA. The proposed Study would be a “Situation Analysis to understand the prescription and referral pattern of Hospitals and Medical Practitioners and also the tie-ups and networking amongst various stakeholders in Health Care Sector”. The proposed Study is to be confined to allopathic health care only. The objectives of the proposed Study are:
a) To enhance the understanding of the Pharmaceutical and Health Care sector from the perspective of competition;
b) To understand the state of competition across various levels of the Pharmaceutical and Health Care sector;
c) To identify areas of competition concern;
d) To identify measures to address areas of concerns and advocate competition in pharmaceutical and health care sector;
e) To provide input for the policy makers/concerned authorities backed by credible data and;
f) To assess the awareness and effectiveness of the decisions of the Commission relating to pharmaceutical and health care sector.
